In comparison, aFGF treatment largely reversed these changes (the statistical significance of differences of both the Bcl-2/Bax ratio and cleaved caspase-3 level between the T2DM + aFGF vs. T2DM groups was P < 0.05). The gene discussed is CASP3; the disease is type 2 diabetes mellitus.